EGCG prevents obesity-induced precocious puberty by reshaping lipid metabolism, with key enzymes (PISD, PLD, and PTDSS) in glycerophospholipid metabolism serving as potential therapeutic targets. The gene discussed is GPLD1; the disease is obesity disorder.